Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.
about
Phase II study of sunitinib malate in patients with recurrent high-grade glioma.Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors--review of assay methodologies and perspectives.A biodegradable perivascular wrap for controlled, local and directed drug delivery.Activation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts.Tissue sample preparation in bioanalytical assays.Bioanalysis of drug in tissue: current status and challenges.MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.Antineoplastic drugs and their analysis: a state of the art review.Therapeutic drug monitoring and tyrosine kinase inhibitors.Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies.Sunitinib treatment for multiple brain metastases from jejunal gastrointestinal stromal tumor: case report.Tubacin prevents neuronal migration defects and epileptic activity caused by rat Srpx2 silencing in utero.Quantitation of sunitinib, an oral multitarget tyrosine kinase inhibitor, and its metabolite in urine samples by nonaqueous capillary electrophoresis time of flight mass spectrometry.Application of paper spray-MS in PK studies using sunitinib and benzethonium as model compounds.Rapid Determination of 10 Parabens in Spices by High Performance Liquid Chromatography-Mass Spectrometry
P2860
Q33392046-FAF3A3CF-7879-4FA6-AB68-F80B81114340Q34460026-0558FE6B-60D6-4096-AC4F-66177A60A249Q35039240-D2F526DE-619C-4CFA-8CBD-9F57A4783DB8Q35311474-603F895E-3EEE-4038-A841-CF4D87926D9FQ35450340-FA327B13-5DD2-4DDF-9548-45C957CFA64EQ36044303-0CE53247-DF24-44ED-9C4A-50BEBAC6B4CAQ36335477-1BAD4C25-F176-404D-9FAD-F233EED6B58CQ37997452-69DB8D53-422C-434F-AA71-1EDD609A83AAQ38061687-C5503CA8-4F87-4C0E-8885-D5BD63878FB4Q38750187-C52F4935-07BE-4FE8-8739-B664A06FA31AQ39339684-B0EE68A5-4142-4080-AED7-C5BC3804EA4EQ41846251-364007A4-EA3E-4D28-B102-06484272CBDCQ41853401-DA4E765C-99F0-4CFC-B6A9-910D791F1066Q42137803-51C6DF33-C694-49CC-B64B-EFB14FE8990DQ50735365-AD98EDAA-5C98-4F4A-B304-1AC6920A73D8Q53542598-2E51021D-AF2B-4E75-97F9-72949D79561DQ53586859-D0FBCE42-3B80-4C48-9519-41B6600F42C3Q58283915-F9CDA0B1-7DA4-40B5-B107-5BC3C859C289
P2860
Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantification of sunitinib in ...... d pharmacokinetic application.
@ast
Quantification of sunitinib in ...... d pharmacokinetic application.
@en
type
label
Quantification of sunitinib in ...... d pharmacokinetic application.
@ast
Quantification of sunitinib in ...... d pharmacokinetic application.
@en
prefLabel
Quantification of sunitinib in ...... d pharmacokinetic application.
@ast
Quantification of sunitinib in ...... d pharmacokinetic application.
@en
P2860
P1476
Quantification of sunitinib in ...... d pharmacokinetic application.
@en
P2093
James M Gallo
Qingyu Zhou
P2860
P304
P356
10.1016/J.JPBA.2009.10.006
P577
2009-10-12T00:00:00Z